PATENTS IN THE PHARMACEUTICAL INDUSTRY: ROLE AND STRATEGIES
DOI:
https://doi.org/10.53555/ssh.v11i1.2471Keywords:
pharmaceutical, innovation, public health, research, development, businessAbstract
To safeguard intellectual property, encourage innovation, and recover large expenditures in research and development (R&D), the pharmaceutical business mostly depends on patents. Patents pose questions regarding accessibility, pricing, and ethical behavior even while they give exclusive rights that can spur medical progress. This essay examines the many facets of patents in the pharmaceutical industry, including their advantages, difficulties, and the fine line that separates innovation from public health. The purpose of the study is to present a comprehensive understanding of how patents impact the pharmaceutical industry through an analysis of patent strategy, legal frameworks, and case studies
Downloads
References
Faunce, T. (2004). The awful truth about evergreening. Australian and New Zealand Health Policy. 
Feldman, R. (2018). May your drug price be evergreen. Journal of Law and Biosciences. 
Carrier, M. A., &Shadowen, S. D. (2017). Product Hopping: A New Framework. Notre Dame Law Review. 
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013). 
Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012). 
Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act), Pub.L. 98–417 (1984). 
The Treasure of Mumbai. (2006). Wired. 
How Drug Makers Manipulate Patents to Keep Insulin Prices High. (2023). Time. 
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis. (2023). Time. 
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene? (2020). International Review of Intellectual Property and Competition Law. 
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal For Research In Social Science And Humanities
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in
